Blood-based and genetic analyses indicate that free testosterone rather than total testosterone is involved in prostate cancer development. (2022)

From the publication:

In this first comprehensive analysis with both blood-based and genetic data, our results suggest that higher calculated free testosterone is associated with an elevated risk for prostate cancer, including aggressive disease. Neither circulating total testosterone nor SHBG [sex hormone-binding globulin] was associated with elevated risks for prostate cancer.